Charting MSL Activity and Performance (2017)

A unique survey-based report providing key insights and actionable intelligence about MSL activity and performance.

Charting MSL Activity and Performance (2017) distils key findings from one of the most comprehensive surveys of US and EU5 Medical Science Liaison (MSL) personnel. Informed by the responses of 100 MSLs working in top pharma companies, the study identifies critical variations in MSL activity and performance measurement.

Building on the ground-breaking 2015 study, this 2017 version provides comparative analysis to show how priorities and practice have changed over the past two years and where MSLs see further change in the future.

Order today to gain insights on how to benchmark your MSL plans and prioritise engagement techniques used by leading pharma companies.

Example of companies that participated in this study

Gain Answers to Critical Questions

Report Deliverables

At what drug development stage is an MSL team established, how many brands do they handle and how does this differ between the US and Europe?
How do MSL performance measurement criteria change pre to post launch?
Building new KOL relationships is a critical post launch activity, but what outcomes are sought and how is success measured?
To what extent do US and European views differ on MSL activity in CME, medical congress attendance, investigator initiated trials and on the provision of support to physicians in relation to patient access and patient education?
What performance criteria do MSL experts see as becoming increasingly important over the near term and how has this changed in the last 2 years?
How many and at what frequency do MSLs contact KOLs/Physicians and what is the most popular means of communication?
How has the rise of new stakeholders changed the way MSL performance is measured?
What metrics are companies using to demonstrate MSL value?

Your report purchase gives you access to unique data and analysis you can use practically to shape MSL plans and hone performance measurement:

Data Study: Over 100 clear and concise charts that depict the current state and future outlook for MSL activity and performance assessment
Data Tabulations: All the survey data provided in MS Excel
Survey Questionnaire: delivered as a PDF document

Key Takeaways

Understand which MSL activities are seen as being most important in the US and Europe
Benchmark your own MSL activity plans and identify new ways to improve performance
Understand thinking in key areas such as KOL engagement, medical congress attendance and investigator initiated trials
Examine how US/European MSLs view the value of delivering scientific presentations to KOLs and physicians, and learn about the decline of this activity in the US
Identify the most widely used measurements for evaluating MSL-KOL engagement and feedback
Know which performance metrics are preferred for demonstrating value to internal stakeholders
Learn how thinking towards measuring MSL performance has changed over the past 2 years
Understand the current balance between quantitative and qualitative metrics used to measure
MSL performance, and assess signals that may indicate a change in the metrics used in future

About the Survey

Interview Methodology:
Data collected via a 25-minute internet-based questionnaire

Screening Criteria:
Respondents were screened to ensure that they are MSLs or MSL managers / directors who work at a pharmaceutical company ranked in the top 100 by revenue

Sample Distribution:
A total of 100 US-/EU5-based MSLs and MSL managers/directors who work for pharmaceutical companies ranked in the top 100 by revenue

Features of the Survey – Not Available Elsewhere

Knowledgeable and detailed insights from 100 senior MSLs in the US and Europe.
Practical ideas for improving MSL effectiveness and increasing KOL engagement
Valuable benchmarking indicators to assess your MSL programme against peers
Critical insights for corporate management needing to ensure effective physician communication, engagement and brand support

Benchmark your MSL plans and activities >

MSL Activities

Number of Brands Supported and Areas of Responsibility
Assignment of MSLs to Brands and Discussion of New Products with Physicians
MSL Pre-Launch and Post-Launch Activities
Numbers and Methods of Interactions With Physicians
Time Spent on Proactive vs. Reactive Engagement

MSL Performance Measurements

Internal Communication Frequency and Format
Performance Measurements Used to Evaluate MSLs
Methods to Gather Information on External Value Metrics
Frequency of Performance Review

Value Demonstration to Internal Stakeholders of MSL Performance Measurements

Usefulness of MSL Performance Measurements in Value Demonstration
Expected Changes in MSL Performance Measurements in Value Demonstration

Appendix

Screeners – MSL profile

About FirstWord

FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence.

FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your company’s success.
FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. Covering biosimilars, market access, medical affairs, sales & marketing, technology and therapy areas, FirstWord Reports provide expert views and intelligence on the challenges facing pharma today.

Learn more at www.firstwordgroup.com.

Questions? Please contact us at info@fwreports.com.